Biologic response modifiers, also known as biologics, are a newer class of therapeutic proteins used to treat uveitis by inhibiting bioactive mediators or cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-2. Here, TNF is linked to uveitis.